Relevant bibliographies by topics / DEVDC

Academic literature on the topic 'DEVDC'

Author: Grafiati
Published: 10 December 2022
Last updated: 28 January 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Contents

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'DEVDC.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "DEVDC"

1

Foroughipour, Mohsen, Zeinab Nikbin, Maryam Sahebari, Masoud Pezeshki Rad, and Ali Shoeibi. "Devic Syndrome." Journal of Clinical Rheumatology 18, no. 8 (December 2012): 419–21. http://dx.doi.org/10.1097/rhu.0b013e318277a9de.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Papeix, Caroline. "Maladie de Devic." La Presse Médicale 35, no. 11 (November 2006): 1703–6. http://dx.doi.org/10.1016/s0755-4982(06)74884-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Berglöff, J., and G. Ranner. "Neuromyelitis optica Devic." Spektrum der Augenheilkunde 8, no. 3 (June 1994): 142–46. http://dx.doi.org/10.1007/bf03163923.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Duhin, E., M. Giroux, A. Etxeberria, E. Boyle, H. Zephir, X. Leleu, and P. Vermersch. "Un « Devic » indolent." Revue Neurologique 169 (April 2013): A103—A104. http://dx.doi.org/10.1016/j.neurol.2013.01.248.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Miyazawa, Isabelle, Kazuo Fujihara, and Yasuto Itoyama. "Eugène Devic (1858-1930)." Journal of Neurology 249, no. 3 (March 1, 2002): 351–52. http://dx.doi.org/10.1007/s004150200020.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Ueda, Kyoko, Noriko Nishimura, Yuko Mishima, Hideaki Nitta, Yoshiharu Kusano, Masahiro Yokoyama, Naoko Tsuyama, et al. "RT-DeVIC Therapy Is Effective for Localized NK/T Cell Lymphoma Patiens." Blood 124, no. 21 (December 6, 2014): 1702. http://dx.doi.org/10.1182/blood.v124.21.1702.1702.

Full text
Abstract:
Abstract BACKGROUNDS: Extranodal natural killer (NK) /T cell lymphoma, nasal type is much common in East Asia than in Western countries. CHOP therapy is not effective for NK/T cell lymphoma because of the drug resistance induced by P glycoprotein. Yamaguchi et al reported the effectiveness of concurrent radiotherapy and DeVIC (RT-DeVIC) therapy for localized nasal NK/T cell lymphoma. Nowadays, RT-DeVIC therapy is recognized as a standard treatment. So far, we have limited information about this treatment because NK/T cell lymphoma is rare phenotype. PATIENTS AND METHODS: We reviewed retrospectively the patients with localized NK/T cell lymphoma treated with RT-DeVIC therapy. Radiation therapy was administered for a total dose of 50 Gy. Concurrently, chemotherapy with dexamethasone, etoposide, ifosfamide, and carboplatin (DeVIC) was performed up to 3 cycles. The primary objectives of this analysis were to evaluate the response rates and progression free survival (PFS) and overall survival (OS). RESULTS: A total of 20 patients who diagnosed as nasal NK/T cell lymphoma between April 2007 and October 2012 were analyzed. Sixteen patients were stage 1E and 4 were Stage 2E. As the NK/T cell lymphoma prognostic index, 6 patients were group 1, 10 were group 2, 3 were group 3, and 1 was group 4. Seventeen patients completed 3 cycles of DeVIC therapy and 19 patients completed planned radiation therapy. Overall response rate (ORR) was 75% and CR rate was 70% in the entire patients. Local control was 90%. Half of the patients who reached CR showed long time survival without disease progression. On the other hand, 7 of 14 patients relapsed after CR, and all 5 patients experienced systemic failure. The sites of relapse were paranasal sinuses (n=2), skin (n=3), brain (n=1), testis (n=1). Among them, one patient reached 2nd CR. However, 5 patients were not eligible for salvage chemotherapy, because lymphoma progressed rapidly and their general condition became worse. Six patients did not reach CR after RT-DeVIC therapy. Five of them experienced systemic relapse and median survival of them was only 8 months. The median follow up time was 17.6 months (range 2 – 77.9 months). Median overall survival was not reached and median progression free survival was 14.6 months. Risk factors predicted of OS or PFS were not clear. All entire patients experienced grade 3 or 4 neutropenia. Mucositis was common non-hematological toxicity and it was the major cause of grade 3 or 4 appetite loss. Only one patient discontinued RT-DeVIC due to grade 3 mucositis, grade 3 dermatitis and septic shock. CONCLUSION: We reviewed treatment outcomes of 20 cases of RT-DeVIC therapy. In this analysis, the majority of relapsed or refractory cases showed systemic disease and the prognosis of these patients were poor. However, RT-DeVIC therapy showed excellent local control and response rates which were similar to the prior study. The effectiveness of RT-DeVIC therapy for patients with NK/T cell lymphoma was reconfirmed. Disclosures No relevant conflicts of interest to declare.
APA, Harvard, Vancouver, ISO, and other styles
7

Bibiano, Alana Maiara Brito, Jaqueline Silva Veloso, and Walderi Monteiro da Silva Junior. "Capacidade funcional na doença de Devic." Revista Neurociências 23, no. 4 (December 31, 2015): 603–8. http://dx.doi.org/10.34024/rnc.2015.v23.7993.

Full text
Abstract:
Introdução. A Doença de Devic é uma doença inflamatória, desmie­linizante, imunomediada e necrotizante do sistema nervoso central, caracterizada por afetar o nervo óptico e a medula espinhal. Objetivo. Avaliar a capacidade funcional de uma paciente com Doença de Devic submetida a tratamento clínico e fisioterapêutico. Método. Relato de caso do tipo descritivo, retrospectivo, de abordagem quantitativa, de uma paciente com Doença de Devic. Para avaliação da funcionalidade aplicou-se o questionário Medida de Independência Funcional (MIF) na admissão e alta hospitalar. Na admissão foi constatado o valor de MIF =38, o qual representa total dependência da paciente para suas atividades cotidianas, e na alta a paciente evoluiu seu quadro funcional para independência parcial de suas atividades diárias, representando um valor de MIF=102. Conclusão. A paciente com Doença de Devic obteve melhora na capacidade funcional na alta hospitalar.
APA, Harvard, Vancouver, ISO, and other styles
8

Pinzón, Alfredo, Tatiana Echeverry, and Aida Bibiana Rodríguez. "Neuromielitis óptica (enfermedad de Devic)." Acta Médica Colombiana 35, no. 1 (November 29, 2019): 21–25. http://dx.doi.org/10.36104/amc.2010.1579.

Full text
Abstract:
Presentamos el caso de una mujer joven inicialmente tratada por esclerosis múltiple, quien presentó recurrencia con compromiso ocular severo. La enfermedad de Devic es un desorden desmielinizante que se presenta como una mielitis transversa asociada con neuritis óptica, típicamente bilateral. El principal diagnóstico diferencial es justamente la esclerosis múltiple
APA, Harvard, Vancouver, ISO, and other styles
9

Silva, Alexandre R., Sonja V. T. Barros, Newra Tellechea Rotta, Lygia Ohlweiler, Isa Stone, and Letícia R. Mello. "Devic disease: a case report." Jornal de Pediatria 77, no. 6 (November 15, 2001): 522–4. http://dx.doi.org/10.2223/jped.356.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Joshi, Ajit, Milind Suryawanshi, and Satyanarayanamurthy Ayyori. "Neuromyelitis optica: Devic′s disease." Journal of Clinical Ophthalmology and Research 3, no. 1 (2015): 32. http://dx.doi.org/10.4103/2320-3897.149371.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "DEVDC"

1

Thomas, Laurence. "Neuromyelite optique de devic." Nice, 1989. http://www.theses.fr/1989NICE6536.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Blanc, Frédéric. "Neuromyélite optique de Devic : troubles cognitifs et imagerie cérébrale par résonance magnétique." Strasbourg, 2010. https://publication-theses.unistra.fr/public/theses_doctorat/2010/BLANC_Frederic_2010.pdf.

Full text
Abstract:
Etat de la question : La neuromyélite optique (NMO) est une pathologie inflammatoire du système nerveux central se caractérisant par l’association de myélites et névrites optiques. L’IRM cérébrale est le plus souvent normale en début de maladie. Par ailleurs la présence de lésions inflammatoires cérébrales n’a été retrouvée que chez 10% des patients. La recherche d’une atteinte cognitive chez les patients atteints de NMO n’avait jamais été faite jusqu’à présent. Méthodes et résultats : 1. Nous avons comparé le statut cognitif de 30 patients NMO à 30 patients atteints de sclérose en plaques (SEP) et 30 sujets sains en utilisant la batterie BCcogSEP. Les troubles cognitifs chez les patients NMO (57%) étaient comparables aux patients SEP (37%), sous la forme d’un syndrome sous-cortico-frontal. 2. En spectroscopie par résonance magnétique, au niveau de la substance blanche (SB) et la substance grise (SG) d’apparence normale, il n’était pas retrouvé d’anomalies. 3. Le volume cérébral global et focal a été analysé pour 32 sujets NMO et 32 témoins en SB et SG par les méthode SIENAx et VBM. Nous avons trouvé une diminution de volume cérébral en SB à la fois globale et focale, et des corrélations cohérentes entre le volume de SB global, focal et les troubles cognitifs. Conclusion : Ainsi, nous montrons pour la première fois l’existence de troubles cognitifs et une atrophie cérébrale en rapport dans la NMO, alors qu’elle était considérée comme une maladie restreinte à la moelle et aux nerfs optiques. Il convient désormais de tenter de mieux comprendre l’origine de ces troubles cognitifs en analysant plus finement la SB par l’analyse en DTI des faisceaux de fibres et dysconnexions
Background : Neuromyelitis Optica (NMO) is an inflammatory disease of the central nervous system, characterized by myelitis and optic neuritis. Brain MRI is usually normal at the beginning of the disease. Moreover, brain inflammatory lesions are found in less 10% of cases. Cognitive testing has never been done before this study. Methods and Results: We compared 30 NMO patients to 30 multiple sclerosis (MS) patients and 30 healthy subjects, using the BCcogSEP. Cognitive impairment was found to be the same in NMO (57%) and MS (37%) patients: a frontal subcortical cognitive impairment. In MR-spectroscopy, in normal appearing white matter (WM), an grey matter (GM), we found no abnormalities. Global and focal brain volumes were analyzed in 32 NMO patients and 32 controls for WM and GM using SIENAx and VBM methods. We found a diminished global and focal WM, and coherent correlations between global and focal WM and cognitive dysfunctions. Conclusion: We have demonstrated for the first time the existence of cognitive impairment and a correlated atrophy in NMO, although it was considered as a restricted disease to the spinal cord and optic nerves. It is of importance now to better understand the origin of such dysfunction in analyzing the white matter and dysconnexions by DTI
APA, Harvard, Vancouver, ISO, and other styles
3

Krishnamoorthy, Gurumoorthy. "Devic mouse: a spontaneous double-transgenic mouse model of human opticospinal multiple sclerosis and autoimmune T- B cell cooperation." Diss., lmu, 2007. http://nbn-resolving.de/urn:nbn:de:bvb:19-64389.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Sreekanta, Suma. "Programmed cell death and induction of caspase-like protease activity in roots of Glycine max (soybean) in response to flooding stress." Miami University / OhioLINK, 2008. http://rave.ohiolink.edu/etdc/view?acc_num=miami1218082902.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Zheng, Shunsheng. "Arginine methylation in the E2F1 pathway." Thesis, University of Oxford, 2013. http://ora.ox.ac.uk/objects/uuid:0a0e3d43-dedc-490c-92d0-44442c9be1f2.

Full text
Abstract:
The E2F1 pathway plays an important role in coordinating early cell cycle progression. Deregulation of the E2F1 pathway, which may be brought about by somatic mutations in genes such as INK4A, RB1 and CDK4, is found in a majority of cancers. The transcription factor E2F1 is able to activate genes involved in proliferation as well as apoptosis, but the mechanisms that govern these opposing biological effects remain poorly understood. In this study, I would describe how E2F1 activity can be regulated by two novel post-translational modifications which result in different functional consequences. It was found that PRMT1 asymmetrically methylates E2F1 at R109, while PRMT5 symmetrically methylates R111 and R113. The symmetric dimethyl marks on E2F1 promoted the recruitment of Skp2, a component of the E3 ubiquitin ligase complex, which coincided with decreased protein stability and transcriptional activity, as well as enhanced cell proliferation and reduced apoptosis. The asymmetric dimethyl marks on E2F1 was found to hinder symmetric dimethylation, leading to reduced cell proliferation and enhanced apoptosis. The competition between PRMT1 and PRMT5 at the E2F1 RG-rich motif was found to be regulated by the adjacent cyclin A binding site. Induction of DNA damage, which resulted in decreased cyclin A level, corresponded to an increase in PRMT1 and decrease in PRMT5 binding. This study uncovers a new mechanism in E2F1 regulation and establishes the importance of arginine methylation in cell proliferation and apoptosis.
APA, Harvard, Vancouver, ISO, and other styles
6

LISBOA, Edson Barbosa. "DevC: uma linguagem de suporte ao desenvolvimento concorrente de device drives e modelos de controladores de entrada e saída." Universidade Federal de Pernambuco, 2009. https://repositorio.ufpe.br/handle/123456789/1393.

Full text
Abstract:
Made available in DSpace on 2014-06-12T15:49:42Z (GMT). No. of bitstreams: 1 license.txt: 1748 bytes, checksum: 8a4605be74aa9ea9d79846c1fba20a33 (MD5) Previous issue date: 2009
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Produtos eletrônicos modernos integram diversas funcionalidades, combinando mobilidade, poder computacional, uma alta capacidade para comunicação e flexibilidade de interfaceamento. No entanto, a integração dessas funcionalidades eleva a complexidade do projeto. O projeto de tais produtos inclui um sistema embarcado que, em geral, implementa suas funcionalidades em uma solução integrada de hardware e software. Uma plataforma de hardware baseada em processador permite a execução das funcionalidades do software do sistema. Os seus principais componentes são: processadores, memória, barramento e dispositivos periféricos. Modelos de simulação destes componentes podem ser obtidos e conectados para compor um modelo de plataforma virtual. Este modelo pode ser usado, ainda na fase inicial, para o desenvolvimento dos componentes de software: código dependente da plataforma, device drivers, funcionalidades do sistema operacional e aplicações do usuário. Nesse contexto, os dispositivos periféricos e os respectivos device drivers têm um papel importante, pois são responsáveis pelos diversos tipos de comunicação e interfaceamento com o mundo exterior, requisitos obrigatórios na maioria dos sistemas modernos. No entanto, o desenvolvimento de dispositivos periféricos não é uma tarefa simples, ainda que seja um modelo de simulação. Por outro lado, o desenvolvimento do driver depende da disponibilidade do modelo do dispositivo, além do tipo do processador e do sistema operacional. Essas dependências, portanto, podem acarretar atraso no tempo de desenvolvimento e afetar o custo do projeto. Assim, o desenvolvimento integrado e concorrente do dispositivo e do driver facilita a depuração, contribuindo para a eliminação de erro, além de reduzir o tempo total do projeto. Esse trabalho propõe uma abordagem para dar suporte ao desenvolvimento incremental e concorrente de device drivers e modelos de simulação do controlador de dispositivos, considerando diferentes níveis de detalhes dos modelos, o tipo do processador usado, bem como, a utilização de um sistema operacional. Para isso, uma linguagem específica do domínio é proposta para descrever características dos controladores e do device driver e, a partir dessa descrição, possibilitar que o controlador e os drivers sejam sintetizados. Para validar a proposta, uma plataforma baseada no processador Sparc foi desenvolvida e um porte do sistema operacional uclinux foi realizado. Alguns dispositivos periféricos e seus respectivos device drivers foram sintetizados tais como, UART, LCD display e dispositivos específicos para plataformas de computação reconfigurável. Esses componentes foram integrados à plataforma base e simulados para a validação dos componentes
APA, Harvard, Vancouver, ISO, and other styles
7

Dreykluft, Angela [Verfasser], and Heinz [Akademischer Betreuer] Wiendl. "The PD-1/B7-H1 Pathway in a Transgenic Mouse Model for Spontaneous Autoimmune Neuroinflammation : Immunological Studies on Devic B7-H1-/- Mice / Angela Dreykluft. Betreuer: Heinz Wiendl." Würzburg : Universitätsbibliothek der Universität Würzburg, 2013. http://d-nb.info/1042899444/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Yun, Seonho. "Intracellular Microenvironment Triggered Co-delivery of Anticancer Drugs and Genes." Thesis, 2019. http://hdl.handle.net/2440/120605.

Full text
Abstract:
Currently, infallible cancer treatment has not been achieved. Doxorubicin (DOX), an active anticancer drug, initiates the apoptotic signaling pathway by intercalating topoisomerase-II, resulting in DNA replication disorder and producing reactive oxygen species that can damage DNA and activate cell death receptors. However, long-term DOX administration is always accompanied with serious multidrug resistance (MDR) and adverse side-effects. Therefore, delivery systems for DOX and gene drug, such as miRNA-21 inhibitor (miR-21i) which mitigates MDR, have been developed to reduce side-effects caused by non-selective cellular uptake of co-drugs in the absence of suitable delivery systems. However, difficulties in designing delivery systems for different types of drugs to achieve both high therapeutic efficacy and low side-effects have been reported. In this thesis, various biodegradable and biocompatible smart microgels are developed for DOX and gene co-delivery to achieve maximal anticancer performance and minimal side-effects. The microgel delivery carriers are prepared by crosslinking biocompatible low molecular weight polyethyleneimine (PEI800) using glutathione-cleavable diselenide crosslinkers. To the carriers, DOX is conjugated via various intracellular microenvironment sensitive linkers, and genes are electrostatically loaded to glutathione-cleavable polyethyleneimine. Finally, anionic hyaluronic acid (HA) surface coating is able to inhibit serum protein adsorption during blood circulation and promote HA receptor-mediated endocytosis for selective metastatic cancer cells. The hydrodynamic sizes of resulting nano-drugs at 100–200 nm allow prolonged circulation. The developed nano-drugs degrade into less than 10 nm fragments in the glutathione-rich cytosol of cancer cells by cleaving diselenide crosslinkers, allowing intensive gene release and complete urinary excretion. Real-time tracks of release profiles are developed using fluorescence quenching technique. On the other hand, to eliminate premature release, DOX is conjugated to microgel carriers through various linkers for efficiently controlled spatiotemporal release in cancer lysosomes, such as acid-responsive hydrazone linkers, glutathione-cleavable diselenide linkers and enzyme-cleavable peptide linkers. The system comprising of DOX with a hydrazone bond demonstrates 4.4-fold higher in vitro anticancer performance on MDA-MB-231 cell line than free DOX. The nano-drug system of miR-21i and conjugated DOX via hydrazone and diselenide dual bonds completely surpasses DOX premature leakage in physiological condition and results in a high survival rate of over 95 % for HEK293T kidney cell line at a DOX concentration of 2.5 μg mL−1, but it reveals 3.2-fold increase in therapeutic effect on the multidrug-resistant cancer cell line of MDA-MB-231-R12w compared with free DOX. To simplify DOX loading process, diselenide crosslinkers can be used for both microgel synthesis and DOX conjugation to produce a simultaneous release system of gene and DOX in cytosol. The introduction of ATP aptamer to the miR-21i and DOX co-delivery system further increases intracellular DOX accumulation in MDA-MD-231-R12w cells with 4.2-fold higher anticancer performance than free DOX but with low cytotoxicity to healthy cells. To achieve sequential release, the nano-drug system of miR-21i and conjugated DOX with a caspase-3-cleavable DEVDC peptide linker enables the step release of miR-21i followed by DOX. Compared with free DOX, this systems demonstrates a 7.3-fold increase in anticancer effect on MDA-MB-231-R24w and negligible side effects. In summary, we have developed various smart nano-drugs with outstanding advantages of low cytotoxicity, complete biodegradability, targeting and selective delivery and high anticancer performance to MDR cells. Our approach suppresses traditional gene and drug delivery concepts, and advances knowledge for successive design of delivery systems in clinical applications.
Thesis (Ph.D.) -- University of Adelaide, School of Chemical Engineering and Advanced Materials, 2019
APA, Harvard, Vancouver, ISO, and other styles
9

Chang, Jing-Teng, and 張靖騰. "Design of Global Universality Antenna in the Mobile Devic." Thesis, 2015. http://ndltd.ncl.edu.tw/handle/46kzqt.

Full text
Abstract:
碩士
國立交通大學
電機學院電信學程
103
This paper proposes a compact multiband internal antenna for handset applications. The antenna is composed of a planar polygon antenna, and a coupled strip line connected to a meandered short-end strip and an open-end strip. Three types of antenna are excited, namely wideband antenna, loop antenna and inverted F antenna (PIFA). Parameters studies on the proposed geometry have been demonstrated. After the related parameters are controlled, the bandwidth of this antenna has the potential to cover 2G, 3G, and 4G mobile bands of GSM (824–960MHz), DCS (1710–1880 MHz), PCS (1850–1990 MHz), UMTS (1920–2170 MHz), full LTE bands (FDD–LTE bands 1–28 and TDD–LTE bands 33–43), and even can cover the WiFi 5G services. Good radiation characteristics, gain, and radiation efficiency are obtained over these operating bands. This antenna is suitable for the metal casing of handheld devices.
APA, Harvard, Vancouver, ISO, and other styles
10

Song, Chang-Ping, and 宋張平. "A Dynamic Analysis of Quantum-well Devic from Time-Dependent Schrodinger Equation." Thesis, 1993. http://ndltd.ncl.edu.tw/handle/47204043160750746487.

Full text
Abstract:
碩士
國立成功大學
電機工程研究所
81
The Schrodinger equation is very important in quantum and the wavefunction is the solution of the Schrodinger equation. Many physical phenomena and quantities can be analyzed from the wavefunction. So, that is a good method to analyze the dynamic phenomena of the quantum-well device from the time-dependent equation. But it is difficulty in handing open-system boundary This paper presents a new numerical method of the time- dependent Schrodinger equation and a good boundary condition method to the interaction with ideal particle reservoire at the open-system boundaries. Furthermore, this paper discusses the dynamic of asymmetric coupled quantum-well and double-barrier quantum well structures to sustain the new numerical method and the boundary conditions of the open-system.
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "DEVDC"

1

Bokova, V. M., and L. G. Sacharova. Institutki: Vospominanija vospitannic institutov blagorodnych devic. 3rd ed. Moskva: Novoe literaturnoe obozrenie, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Tantiwiramanond, Darunee. Development and Education Program for Daughters and Communities Center (DEPDC). Bangkok, Thailand: Women's Action and Resource Initiative, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Jiménez, Wilfredo. Quién dijo miedo, Devic?: Y siempre Florencio Sánchez : biografia dramatizada. Buenos Aires: Nueva Generación, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

To hear the angels sing: An odyssey of co-creation with the devic kingdom. Hudson, NY: Lindisfarne Press, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Barkel, K., and I-em-hotep. Devic Initiation. Kessinger Publishing, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Devda Historica. Gremio De Editores, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Reciprocidad, Don Y Devda. Gremio De Editores, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

PILBERY. Standby Cpd Conducted Electrical Devic. Class Publishing, 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

NA. Electrnc Devic& Circ Thry& Multisim Ste8 Pk. Addison Wesley Longman, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Elect Devc Desgn and ph Math. Pearson Education, Limited, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "DEVDC"

1

Chapman, Joab. "Neuromylelitis Optica (Devic Syndrome)." In Diagnostic Criteria in Autoimmune Diseases, 433–34. Totowa, NJ: Humana Press, 2008. http://dx.doi.org/10.1007/978-1-60327-285-8_79.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Xiong, Chiyi, Zhi Yang, Rui Zhang, William Tong, Juri Gelovani, and Chun Li. "99mTc-labeled Ac-DEVD Peptides as a Substrate for Measuring Caspase Activity." In Advances in Experimental Medicine and Biology, 455–56. New York, NY: Springer New York, 2009. http://dx.doi.org/10.1007/978-0-387-73657-0_197.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Enna, S. J., and David B. Bylund. "Ac-DEVD-CHO." In xPharm: The Comprehensive Pharmacology Reference, 1. Elsevier, 2007. http://dx.doi.org/10.1016/b978-008055232-3.63234-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Behera, Ajit Kumar, and Mrutyunjaya Panda. "Efficient Software Reliability Prediction With Evolutionary Virtual Data Position Exploration." In Advances in Data Mining and Database Management, 275–85. IGI Global, 2021. http://dx.doi.org/10.4018/978-1-7998-6659-6.ch016.

Full text
Abstract:
Determining appropriate software reliability prediction technique is a challenging task for the software development process. So, it is essential for software engineers to develop good quality software product. Though several prediction models are in use for small size data, the estimation of the reliability of software system is crucial. Inadequate data may lead sub-optimal solution. This chapter proposes a technique of increasing training dataset by generating virtual data points original data. For improving the prediction of cumulative failure time in software, multilayer perceptron (MLP)-based virtual data positions (DEVDP) exploration techniques have been proposed. The parameters of the network are optimized by evolutionary algorithm differential evolution (DE). For validation of the model in presence of virtual data point (VDP), eight failure datasets from different sources has been used. The results obtained from the simulation studies indicate that proposed DEVDP exploration technique outperformed traditional models.
APA, Harvard, Vancouver, ISO, and other styles
5

Silva, Felix Augusto do Carmo, and Gabriella Eldereti Machado. "A EDUCAÇÃO AMBIENTAL E OS DESAFIOS DO SÉCULO XXI: UMA ANÁLISE ACERCA DO USO DE COPOS DESCARTÁVEIS NO DEPARTAMENTO DE EDUCAÇÃO (DEDC) CAMPUS VII/UNEB." In A educação enquanto fenômeno social: Perspectivas de evolução e tendências, 86–95. Atena Editora, 2022. http://dx.doi.org/10.22533/at.ed.1022225118.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "DEVDC"

1

"[DevIC 2021 Front cover]." In 2021 Devices for Integrated Circuit (DevIC). IEEE, 2021. http://dx.doi.org/10.1109/devic50843.2021.9455929.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Al-Mojahed, Mahmoud Abdullah, and Basheer Mohamad Al-Maqaleh. "DEADC: Density Extending Algorithm for Data Clustering." In 2022 2nd International Conference on Emerging Smart Technologies and Applications (eSmarTA). IEEE, 2022. http://dx.doi.org/10.1109/esmarta56775.2022.9935508.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Weipeng Jing and Yaqiu Liu. "DECDC: An energy-aware route protocol for wireless sensor networks." In 2008 2nd International Symposium on Systems and Control in Aerospace and Astronautics (ISSCAA). IEEE, 2008. http://dx.doi.org/10.1109/isscaa.2008.4776216.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Koshy, K. I., A. M. Juby, V. Namboodiri, and M. Overcash. "Can cloud computing lead to increased sustainability of mobile devic?" In 2012 IEEE International Symposium on Sustainable Systems and Technology (ISSST 2012). IEEE, 2012. http://dx.doi.org/10.1109/issst.2012.6228019.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

PIRES, CATARINA FERNANDES, ROBERTA ORIANA ASSUNÇÃO LOPES DE SOUSA, SIMONE SOARES LIMA, ANA TERESA SPÍNDOLA MADEIRA CAMPOS, ALZIRA ALMEIDA DE SOUSA CASTRO, APARECIDA MAÍSA DE CARVALHO GOMES, VALÉRIO CHAVES PINTO JÚNIOR, et al. "DEVIC´S NEUROMYELITIS OPTICA ASSOCIATED WITH JUVENILE DERMATOMYOSITIS: CASE REPORT." In 36º Congresso Brasileiro de Reumatologia. São Paulo: Editora Blucher, 2019. http://dx.doi.org/10.5151/sbr2019-080.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Carretero, Claudio, Jesus Acero, and Jose M. Burdio. "Double Inverter with Common Resonant Capacitor for Elliptical Coil Induction Heating Devic." In 2021 IEEE Applied Power Electronics Conference and Exposition (APEC). IEEE, 2021. http://dx.doi.org/10.1109/apec42165.2021.9487357.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Iwasaki, Wataru, Nobutomo Morita, Chiaki Sakurai, Yuta Nakashima, Yoshitaka Nakanishi, and Masaya Miyazaki. "Development of a Thermoresponsive Valve Membrane for Microfluiic Paper-Based Analytical Devic." In 2019 20th International Conference on Solid-State Sensors, Actuators and Microsystems & Eurosensors XXXIII (TRANSDUCERS & EUROSENSORS XXXIII). IEEE, 2019. http://dx.doi.org/10.1109/transducers.2019.8808184.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Mitchell, Michael W., Xuezhu Liu, Yannick Bejat, Dimitris E. Nikitopoulos, Steven A. Soper, and Michael C. Murphy. "Modeling and validation of a molded polycarbonate continuous-flow polymerase chain reaction devic." In Micromachining and Microfabrication, edited by Holger Becker and Peter Woias. SPIE, 2003. http://dx.doi.org/10.1117/12.478142.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Bao, J., B. Gysen, and E. Lomonova. "Hybrid analytical modeling of saturated electromagnetic devic-es: Integration of Fourier modeling and magnetic equivalent circuits." In 2018 IEEE International Magnetic Conference (INTERMAG). IEEE, 2018. http://dx.doi.org/10.1109/intmag.2018.8508848.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

"Table of Contents." In 2021 Devices for Integrated Circuit (DevIC). IEEE, 2021. http://dx.doi.org/10.1109/devic50843.2021.9455830.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'DEVDC' for particular source types:
Journal articles Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography